首页 > 最新文献

Current Pediatric Reviews最新文献

英文 中文
Effects of Breast Milk or Supplemented Formula Milk on Fecal Metabolomic Profile. 母乳或补充配方奶对粪便代谢组学的影响。
IF 1.6 Q3 PEDIATRICS Pub Date : 2026-01-01 DOI: 10.2174/0115733963341570250422095946
Giuseppe De Bernardo, Fabio Centanni, Marta Improta, Valeria Crisci, Maurizio Giordano, Giuseppe Buonocore, Serafina Perrone

Breast milk (BM) is the best option for the nutritional needs of an infant. In situations where breastfeeding is contraindicated, donor human milk and formula milk (FM) are suggested as alternatives. This study highlights findings from two studies that evaluated how different dietary patterns (standard formula, post-biotic fermented formula, and breast milk) affected the intestinal microbiota and metabolome of late preterm and full-term infants. The metabolome of late preterm newborns showed a higher presence of metabolites-such as azelaic acid, N-acetylglucosamine- 6- sulfate, and 13(S)-hydroperoxylinolenic acid-in those fed postbiotic-fermented formula, similar to breastfed full-term newborns. The fecal metabolites of breast milk and substitute feeding systems are comparable in these preliminary studies, confirming the effectiveness of formula preparations as breast milk substitutes. Furthermore, newborns fed with postbiotic-supplemented formula or breast milk had several similarities in fecal metabolites. The addition of postbiotics to formula milk appears to be more efficient than standard formula milk and is considered a better alternative to breast milk.

母乳是婴儿营养需求的最佳选择。在禁止母乳喂养的情况下,建议使用供体母乳和配方奶作为替代方案。本研究强调了两项研究的结果,这两项研究评估了不同的饮食模式(标准配方奶粉、生物后发酵配方奶粉和母乳)如何影响晚期早产儿和足月婴儿的肠道微生物群和代谢组。晚期早产新生儿的代谢组显示出较高的代谢物的存在,如壬二酸、n -乙酰氨基葡萄糖-6-硫酸盐和13(S)-氢过氧亚麻酸,在那些喂养生物后发酵配方奶粉的婴儿中,类似于母乳喂养的足月新生儿。在这些初步研究中,母乳和替代喂养系统的粪便代谢物具有可比性,证实了配方制剂作为母乳替代品的有效性。此外,用生物后补充配方奶粉或母乳喂养的新生儿在粪便代谢物方面有几个相似之处。在配方奶中添加后生物制剂似乎比标准配方奶更有效,被认为是母乳的更好替代品。
{"title":"Effects of Breast Milk or Supplemented Formula Milk on Fecal Metabolomic Profile.","authors":"Giuseppe De Bernardo, Fabio Centanni, Marta Improta, Valeria Crisci, Maurizio Giordano, Giuseppe Buonocore, Serafina Perrone","doi":"10.2174/0115733963341570250422095946","DOIUrl":"10.2174/0115733963341570250422095946","url":null,"abstract":"<p><p>Breast milk (BM) is the best option for the nutritional needs of an infant. In situations where breastfeeding is contraindicated, donor human milk and formula milk (FM) are suggested as alternatives. This study highlights findings from two studies that evaluated how different dietary patterns (standard formula, post-biotic fermented formula, and breast milk) affected the intestinal microbiota and metabolome of late preterm and full-term infants. The metabolome of late preterm newborns showed a higher presence of metabolites-such as azelaic acid, N-acetylglucosamine- 6- sulfate, and 13(S)-hydroperoxylinolenic acid-in those fed postbiotic-fermented formula, similar to breastfed full-term newborns. The fecal metabolites of breast milk and substitute feeding systems are comparable in these preliminary studies, confirming the effectiveness of formula preparations as breast milk substitutes. Furthermore, newborns fed with postbiotic-supplemented formula or breast milk had several similarities in fecal metabolites. The addition of postbiotics to formula milk appears to be more efficient than standard formula milk and is considered a better alternative to breast milk.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":" ","pages":"20-24"},"PeriodicalIF":1.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143988926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Quantitative Review of Un-licensed and Off-label Medicines Use in Children Aged 0-2 Years in the Private Sector in South Africa: Extent, Challenges, and Implications. 对南非私营部门 0-2 岁儿童无证和标示外用药的定量研究:程度、挑战和影响》。
IF 1.6 Q3 PEDIATRICS Pub Date : 2026-01-01 DOI: 10.2174/0115733963303583240820043749
Hlayiseka Mathevula, Moliehi Matlala, Natalie Schellack, Samuel Orubu

Background: The global lack of suitable formulations for children leads to off-label and unlicensed medicine use, posing significant risks of adverse effects. Understanding this usage on a national level can help guide interventions for better formulations. This study aimed to measure the prevalence of off-label and unlicensed medicines among children in South Africa's private sector.

Methods: The study used a point prevalence methodology to review medicine use in children aged 0-2 years enrolled in a selected pharmaceutical benefit management company in South Africa from January to June 2022. A sample size of 1055 prescriptions was calculated using a 90% confidence interval, 50% prevalence rate, and 5% error margin. A systematic random sampling approach selected every 7th entry from 91,973 total entries, resulting in a final sample size of 13,139. Data included patient age, number and characteristics of medicines, quantity, and indications. Descriptive statistics analysed and reported the prevalence of unlicensed and off-label medicine use.

Results: Among the 13,139 prescribed medicines, 40% (5,246) were off-label or unlicensed, and 60% (7,893) were on-label. Of the off-label/unlicensed medicines, 16.85% (2,214) were unlicensed, and 23.08% (3,032) were off-label. Methylprednisolone was the top off-label medicine, probiotics were the top unlicensed, and the ICD10 code Z76.9 was the top diagnosis.

Conclusion: The study found that 40% of children aged 0-2 years were prescribed unlicensed or off-label medicines in South Africa's private healthcare sector between January and June 2022. This suggests a widespread practice of off-label or unlicensed prescriptions in paediatric treatment in the South African private sector.

背景:全球范围内缺乏适合儿童的制剂,导致标签外和无证用药,带来巨大的不良反应风险。在全国范围内了解这种用药情况有助于指导采取干预措施,以获得更好的配方。本研究旨在衡量南非私营企业中儿童使用标签外和无证药品的普遍程度:本研究采用点流行方法,对 2022 年 1 月至 6 月期间在南非一家选定的药品福利管理公司注册的 0-2 岁儿童的用药情况进行了调查。按照 90% 的置信区间、50% 的流行率和 5% 的误差率计算出 1055 份处方的样本量。系统随机抽样方法从 91,973 个条目中每隔 7 个条目抽取一个样本,最终样本量为 13,139 个。数据包括患者年龄、药品数量和特点、数量和适应症。描述性统计分析并报告了无证用药和标签外用药的发生率:在 13,139 种处方药中,40%(5,246 种)属于标签外或无证用药,60%(7,893 种)属于标签内用药。在标签外/无证药品中,16.85%(2214 种)为无证药品,23.08%(3032 种)为标签外药品。甲泼尼龙是标签外用药的首位,益生菌是无证用药的首位,ICD10代码Z76.9是诊断的首位:研究发现,在 2022 年 1 月至 6 月期间,南非私营医疗机构为 40% 的 0-2 岁儿童开具了无证或标签外药品处方。这表明在南非私立医疗机构的儿科治疗中,无标签或无证处方的情况非常普遍。
{"title":"A Quantitative Review of Un-licensed and Off-label Medicines Use in Children Aged 0-2 Years in the Private Sector in South Africa: Extent, Challenges, and Implications.","authors":"Hlayiseka Mathevula, Moliehi Matlala, Natalie Schellack, Samuel Orubu","doi":"10.2174/0115733963303583240820043749","DOIUrl":"10.2174/0115733963303583240820043749","url":null,"abstract":"<p><strong>Background: </strong>The global lack of suitable formulations for children leads to off-label and unlicensed medicine use, posing significant risks of adverse effects. Understanding this usage on a national level can help guide interventions for better formulations. This study aimed to measure the prevalence of off-label and unlicensed medicines among children in South Africa's private sector.</p><p><strong>Methods: </strong>The study used a point prevalence methodology to review medicine use in children aged 0-2 years enrolled in a selected pharmaceutical benefit management company in South Africa from January to June 2022. A sample size of 1055 prescriptions was calculated using a 90% confidence interval, 50% prevalence rate, and 5% error margin. A systematic random sampling approach selected every 7th entry from 91,973 total entries, resulting in a final sample size of 13,139. Data included patient age, number and characteristics of medicines, quantity, and indications. Descriptive statistics analysed and reported the prevalence of unlicensed and off-label medicine use.</p><p><strong>Results: </strong>Among the 13,139 prescribed medicines, 40% (5,246) were off-label or unlicensed, and 60% (7,893) were on-label. Of the off-label/unlicensed medicines, 16.85% (2,214) were unlicensed, and 23.08% (3,032) were off-label. Methylprednisolone was the top off-label medicine, probiotics were the top unlicensed, and the ICD10 code Z76.9 was the top diagnosis.</p><p><strong>Conclusion: </strong>The study found that 40% of children aged 0-2 years were prescribed unlicensed or off-label medicines in South Africa's private healthcare sector between January and June 2022. This suggests a widespread practice of off-label or unlicensed prescriptions in paediatric treatment in the South African private sector.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":" ","pages":"61-70"},"PeriodicalIF":1.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical Way to Use Supraglottic Airway Device. 使用声门上气道装置的实用方法。
IF 1.6 Q3 PEDIATRICS Pub Date : 2026-01-01 DOI: 10.2174/0115733963331390240822105658
Valentina Giovanna Dell'Orto, Virginia Beretta, Chiara Petrolini, Serafina Perrone

We read a review of case reports published on Current Pediatric Reviews 2024 about the use of I-gel® in neonatal complicated intubation, and we decided to write a commentary on the benefits and limitations of using supraglottic airways in neonatal age, with a specific focus on Igel. The use of supraglottic airway devices in neonatal ages is limited to particular conditions, but further research is showing the utility of these devices as the first choice in neonatal resuscitation or airway stabilization. Our commentary highlights the broader practical applications of I-gel and reinforces its role as a valuable tool in neonatal resuscitation.

我们阅读了发表在《当前儿科评论 2024》上的一篇关于在新生儿复杂插管中使用 I-gel® 的病例报告综述,因此我们决定撰写一篇关于在新生儿期使用声门上气道的益处和局限性的评论,并特别关注 Igel [1]。在新生儿期使用声门上气道装置仅限于特殊情况,但进一步的研究表明,这些装置可作为新生儿复苏或气道稳定的首选。我们的评论强调了 I-gel 更广泛的实际应用,并加强了其作为新生儿复苏宝贵工具的作用。
{"title":"Practical Way to Use Supraglottic Airway Device.","authors":"Valentina Giovanna Dell'Orto, Virginia Beretta, Chiara Petrolini, Serafina Perrone","doi":"10.2174/0115733963331390240822105658","DOIUrl":"10.2174/0115733963331390240822105658","url":null,"abstract":"<p><p>We read a review of case reports published on Current Pediatric Reviews 2024 about the use of I-gel® in neonatal complicated intubation, and we decided to write a commentary on the benefits and limitations of using supraglottic airways in neonatal age, with a specific focus on Igel. The use of supraglottic airway devices in neonatal ages is limited to particular conditions, but further research is showing the utility of these devices as the first choice in neonatal resuscitation or airway stabilization. Our commentary highlights the broader practical applications of I-gel and reinforces its role as a valuable tool in neonatal resuscitation.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":" ","pages":"1-3"},"PeriodicalIF":1.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142281844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug Safety Signals for Pediatric Osteopenia and Osteoporosis: A Disproportionality Analysis of USFDA Adverse Event Reporting System. 儿童骨质减少和骨质疏松的药物安全信号:美国食品药品监督管理局不良事件报告系统分析的歧化分析。
IF 1.6 Q3 PEDIATRICS Pub Date : 2026-01-01 DOI: 10.2174/0115733963375307250521100744
Kannan Sridharan
{"title":"Drug Safety Signals for Pediatric Osteopenia and Osteoporosis: A Disproportionality Analysis of USFDA Adverse Event Reporting System.","authors":"Kannan Sridharan","doi":"10.2174/0115733963375307250521100744","DOIUrl":"10.2174/0115733963375307250521100744","url":null,"abstract":"","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":" ","pages":"4-10"},"PeriodicalIF":1.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144141623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preface. 前言。
IF 1.6 Q3 PEDIATRICS Pub Date : 2026-01-01 DOI: 10.2174/0115733963429271250724114215
Giuseppe Buonocore
{"title":"Preface.","authors":"Giuseppe Buonocore","doi":"10.2174/0115733963429271250724114215","DOIUrl":"10.2174/0115733963429271250724114215","url":null,"abstract":"","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":" ","pages":"v"},"PeriodicalIF":1.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144774908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiology Consult for the General Pediatrician after Cardiac Manifestations from a SARS-CoV-2 Infection. SARS-CoV-2感染引起心脏症状后普通儿科医生的心脏病咨询。
IF 1.6 Q3 PEDIATRICS Pub Date : 2026-01-01 DOI: 10.2174/0115733963314978240923110844
Shahnawaz Amdani, Carolyn A Altman, Devyani Chowdhury, Christina Ronai, David Soma, Jeremy M Archer, Seda Tierney, Markus S Renno, Jacob Miller, Quang-Tuyen Nguyen, Julie S Glickstein, William B Orr

The novel Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, created a need for evidence-based guidelines for the evaluation, management, and follow-up after infection. Data have become rapidly available, creating a challenge for medical providers to stay abreast of the ever-evolving recommendations. This article, written collaboratively by pediatric cardiovascular experts, pediatricians, and sports medicine specialists, is focused on SARS-CoV- 2-related pediatric cardiac manifestations. It aims to provide a systematic review of high-yield literature related to all cardiovascular entities as a tool for primary pediatric clinicians to utilize as they consider the cardiac consequences of acute SARS-CoV-2 infection, MIS-C, vaccine-related myocarditis, return-to-play, and long COVID-19 syndrome.

由 SARS-CoV-2 病毒引起的新型 Coronavirus Disease 2019(COVID-19)需要为感染后的评估、管理和随访制定循证指南。数据的快速获得给医疗服务提供者带来了挑战,他们需要及时了解不断变化的建议。本文件由儿科心血管专家、儿科医生和运动医学专家合作撰写,重点关注与 SARS - CoV-2 相关的儿科心脏表现。它旨在系统回顾与所有心血管实体相关的高产文献,作为儿科初级临床医生在考虑急性 SARS-CoV-2 感染、MIS-C、疫苗相关心肌炎、重返赛场和长 COVID-19 综合征的心脏后果时可利用的工具。
{"title":"Cardiology Consult for the General Pediatrician after Cardiac Manifestations from a SARS-CoV-2 Infection.","authors":"Shahnawaz Amdani, Carolyn A Altman, Devyani Chowdhury, Christina Ronai, David Soma, Jeremy M Archer, Seda Tierney, Markus S Renno, Jacob Miller, Quang-Tuyen Nguyen, Julie S Glickstein, William B Orr","doi":"10.2174/0115733963314978240923110844","DOIUrl":"10.2174/0115733963314978240923110844","url":null,"abstract":"<p><p>The novel Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, created a need for evidence-based guidelines for the evaluation, management, and follow-up after infection. Data have become rapidly available, creating a challenge for medical providers to stay abreast of the ever-evolving recommendations. This article, written collaboratively by pediatric cardiovascular experts, pediatricians, and sports medicine specialists, is focused on SARS-CoV- 2-related pediatric cardiac manifestations. It aims to provide a systematic review of high-yield literature related to all cardiovascular entities as a tool for primary pediatric clinicians to utilize as they consider the cardiac consequences of acute SARS-CoV-2 infection, MIS-C, vaccine-related myocarditis, return-to-play, and long COVID-19 syndrome.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":" ","pages":"11-19"},"PeriodicalIF":1.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Association between Prenatal Antibiotic Use and the Risk of Autism Spectrum Disorders among Children: An Updated Meta-Analysis. 产前抗生素使用与儿童自闭症谱系障碍风险之间的关系:一项最新的荟萃分析。
IF 1.6 Q3 PEDIATRICS Pub Date : 2026-01-01 DOI: 10.2174/0115733963352806250512100056
Azam Maleki, Helen Behmanesh, Ensiyeh Jenabi

Background: Studies on prenatal antibiotic use and Autism Spectrum Disorder (ASD) risk have yielded inconsistent results.

Aim: This study aimed to resolve these discrepancies by conducting a meta-analysis on the relationship between prenatal antibiotic use and ASD in children.

Methods: A comprehensive search was conducted in four main databases: Medline (OVID) PubMed, Scopus, and Web of Science, up to August 1, 2024. The analysis employed random-effect models to estimate effect sizes, including hazard ratios (HR) and odds ratios (OR). Publication bias was assessed using Begg's test and Egger's regression test. Subgroup analyses explored variations in the association based on the trimester of pregnancy. The quality of the included studies was assessed using the Newcastle-Ottawa Scale (NOS).

Results: In this meta-analysis, which included twelve studies with a total population of 6,264,831, prenatal antibiotic use was associated with an increased risk of Autism Spectrum Disorder (ASD). The estimated HR for this risk was 1.08 (95% CI: 1.05, 1.12), and the OR was 1.16 (95% CI: 1.09, 1.23), with no detected heterogeneity among studies. The analysis found no publication bias. Significant associations were observed for each trimester: first trimester (HR: 1.11; 95% CI: 1.04, 1.18), second trimester (HR: 1.10; 95% CI: 1.06, 1.14), and third trimester (HR: 1.09; 95% CI: 1.01, 1.18).

Conclusion: The analysis showed that prenatal antibiotic use is a risk factor for ASD. Prenatal antibiotic use was associated with an increase in the risk of ASD across all trimesters of pregnancy. Future research should focus on elucidating the mechanisms underlying this association by examining the effects of specific antibiotic classes, dosages, and timing during critical developmental periods. Longitudinal studies with comprehensive control for confounding factors are essential for strengthening causal inferences and guiding clinical recommendations regarding antibiotic use during pregnancy.

目的:产前抗生素使用与自闭症谱系障碍(ASD)风险的研究结果不一致。目的:本研究旨在通过对儿童产前抗生素使用与ASD之间的关系进行荟萃分析来解决这些差异。方法:综合检索PubMed、Scopus和Web of Science三个主要数据库,检索时间截止到2024年8月1日。分析采用随机效应模型来估计效应大小,包括风险比(HR)和优势比(OR)。采用Begg检验和Egger回归检验评估发表偏倚。亚组分析探讨了基于妊娠三个月的关联变化。纳入研究的质量采用纽卡斯尔-渥太华量表(NOS)进行评估。结果:在这项荟萃分析中,包括12项研究,总人数为5,065,060人,产前抗生素使用与自闭症谱系障碍(ASD)风险增加相关。该风险的估计HR为1.08 (95% CI: 1.05, 1.12), OR为1.16 (95% CI: 1.09, 1.23),研究间未发现异质性。分析没有发现发表偏倚。每个妊娠期均观察到显著相关性:妊娠早期(HR: 1.11;95% CI: 1.04, 1.18),妊娠中期(HR: 1.10;95% CI: 1.06, 1.14)和妊娠晚期(HR: 1.09;95% ci: 1.01, 1.18)。结论:该分析揭示了产前抗生素使用与ASD风险增加之间的重要联系,并且在所有三个月期间风险始终适度升高。未来的研究应侧重于通过检查特定抗生素种类、剂量和关键发育时期的时间来阐明这种关联的机制。综合控制混杂因素的纵向研究对于加强因果推断和指导妊娠期间抗生素使用的临床建议至关重要。
{"title":"The Association between Prenatal Antibiotic Use and the Risk of Autism Spectrum Disorders among Children: An Updated Meta-Analysis.","authors":"Azam Maleki, Helen Behmanesh, Ensiyeh Jenabi","doi":"10.2174/0115733963352806250512100056","DOIUrl":"10.2174/0115733963352806250512100056","url":null,"abstract":"<p><strong>Background: </strong>Studies on prenatal antibiotic use and Autism Spectrum Disorder (ASD) risk have yielded inconsistent results.</p><p><strong>Aim: </strong>This study aimed to resolve these discrepancies by conducting a meta-analysis on the relationship between prenatal antibiotic use and ASD in children.</p><p><strong>Methods: </strong>A comprehensive search was conducted in four main databases: Medline (OVID) PubMed, Scopus, and Web of Science, up to August 1, 2024. The analysis employed random-effect models to estimate effect sizes, including hazard ratios (HR) and odds ratios (OR). Publication bias was assessed using Begg's test and Egger's regression test. Subgroup analyses explored variations in the association based on the trimester of pregnancy. The quality of the included studies was assessed using the Newcastle-Ottawa Scale (NOS).</p><p><strong>Results: </strong>In this meta-analysis, which included twelve studies with a total population of 6,264,831, prenatal antibiotic use was associated with an increased risk of Autism Spectrum Disorder (ASD). The estimated HR for this risk was 1.08 (95% CI: 1.05, 1.12), and the OR was 1.16 (95% CI: 1.09, 1.23), with no detected heterogeneity among studies. The analysis found no publication bias. Significant associations were observed for each trimester: first trimester (HR: 1.11; 95% CI: 1.04, 1.18), second trimester (HR: 1.10; 95% CI: 1.06, 1.14), and third trimester (HR: 1.09; 95% CI: 1.01, 1.18).</p><p><strong>Conclusion: </strong>The analysis showed that prenatal antibiotic use is a risk factor for ASD. Prenatal antibiotic use was associated with an increase in the risk of ASD across all trimesters of pregnancy. Future research should focus on elucidating the mechanisms underlying this association by examining the effects of specific antibiotic classes, dosages, and timing during critical developmental periods. Longitudinal studies with comprehensive control for confounding factors are essential for strengthening causal inferences and guiding clinical recommendations regarding antibiotic use during pregnancy.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":" ","pages":"71-78"},"PeriodicalIF":1.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144076729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiplexed PCR Diagnosis of Bacterial Atypical Pneumonias in the After COVID Era. 新冠肺炎后细菌性非典型肺炎的多重PCR诊断
IF 1.6 Q3 PEDIATRICS Pub Date : 2025-10-15 DOI: 10.2174/0115733963359810251003101314
Kam Lun Ellis Hon, Chamy Luk, Alexander K C Leung, Ada Y F Ip, Ting Fan Leung, Alvin Cheung, Marc L C Yang, Su Yu Qian

Atypical Pneumonia (AP) is any type of pneumonia not caused by one of the common microorganisms, such as Streptococcus pneumoniae. The most common etiologic microorganisms are intracellular bacteria and viruses, including Chlamydia pneumoniae and Mycoplasma pneumoniae. These microorganisms have been difficult to culture. The pandemic of COVID-19 has changed the management of these APs as a result of the widespread usage of multiplexed PCR tests. We have audited 7 anonymized cases of AP to illustrate the utility of these multiplexed PCR-based tests, which can aid the diagnosis and prompt treatment of several AP cases. In conclusion, AP can be readily diagnosed with a multiplexed PCR test, so that efficacious treatment can be initiated without delay. Chlamydia and Bordetella diseases are readily diagnosed even with NPS specimens. Macrolides and doxycycline are readily available oral medications for treating AP in children. Doxycycline is efficacious for macrolide-resistant mycoplasma disease and does not have the side effects of tetracycline in the young pediatric population.

非典型肺炎(AP)是一种不是由常见微生物(如肺炎链球菌)引起的肺炎。最常见的病原微生物是细胞内细菌和病毒,包括肺炎衣原体和肺炎支原体。这些微生物很难培养。由于广泛使用多重PCR检测,COVID-19大流行改变了这些ap的管理。我们审计了7例匿名的AP病例,以说明这些基于聚合酶链反应的多重检测的实用性,它可以帮助诊断和及时治疗一些AP病例。总之,AP可以很容易地通过多重PCR检测诊断,因此可以立即开始有效的治疗。衣原体和博德特拉氏菌病即使用NPS标本也很容易诊断出来。大环内酯类药物和强力霉素是治疗儿童AP的现成口服药物。多西环素对大环内酯耐药支原体疾病有效,并且在年轻儿科人群中没有四环素的副作用。
{"title":"Multiplexed PCR Diagnosis of Bacterial Atypical Pneumonias in the After COVID Era.","authors":"Kam Lun Ellis Hon, Chamy Luk, Alexander K C Leung, Ada Y F Ip, Ting Fan Leung, Alvin Cheung, Marc L C Yang, Su Yu Qian","doi":"10.2174/0115733963359810251003101314","DOIUrl":"10.2174/0115733963359810251003101314","url":null,"abstract":"<p><p>Atypical Pneumonia (AP) is any type of pneumonia not caused by one of the common microorganisms, such as Streptococcus pneumoniae. The most common etiologic microorganisms are intracellular bacteria and viruses, including Chlamydia pneumoniae and Mycoplasma pneumoniae. These microorganisms have been difficult to culture. The pandemic of COVID-19 has changed the management of these APs as a result of the widespread usage of multiplexed PCR tests. We have audited 7 anonymized cases of AP to illustrate the utility of these multiplexed PCR-based tests, which can aid the diagnosis and prompt treatment of several AP cases. In conclusion, AP can be readily diagnosed with a multiplexed PCR test, so that efficacious treatment can be initiated without delay. Chlamydia and Bordetella diseases are readily diagnosed even with NPS specimens. Macrolides and doxycycline are readily available oral medications for treating AP in children. Doxycycline is efficacious for macrolide-resistant mycoplasma disease and does not have the side effects of tetracycline in the young pediatric population.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145336589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Internet Health Information Seeking Behavior of Caregivers in a Tertiary Pediatric Outpatient Setting in Eastern India. 探索互联网健康信息寻求行为的护理人员在三级儿科门诊设置在印度东部。
IF 1.6 Q3 PEDIATRICS Pub Date : 2025-08-28 DOI: 10.2174/0115733963380997250823060812
Manoj Kumar, Swati Swati, Rajan Kumar, Bijit Biswas

Introduction: To study internet health information-seeking behavior and its determinants among caregivers in a tertiary Pediatric Outpatient Department (OPD) in Eastern India.

Methods: A cross-sectional study was conducted between September and December 2022 at the Pediatric Outpatient Department of the All India Institute of Medical Sciences (AIIMS), Deoghar, India. A 13-item validated questionnaire was administered through face-to-face interviews, capturing demographic information and internet health information-seeking behavior. Statistical analyses, including multivariable logistic regression, identified significant determinants.

Results: Outpatient visits were primarily for acute diseases (39.3%), followed by chronic disease monitoring (19.5%) and acute follow-ups (19.3%). Approximately 34.4% of caregivers sought health information online. Internet health information-seeking behavior was significantly associated with higher educational attainment and visit reasons. Caregivers with higher secondary education or graduate degrees were 7.5 and 7.6 times more likely, respectively, to seek health information online. Those attending for acute or acute follow-up visits had 2.2- and 3.5-times higher odds, respectively. The multivariable model explained 32.4% variability and had a predictive accuracy of 74.1%.

Discussion: The relatively low prevalence of online health information-seeking highlights regional gaps in digital health literacy. Education level and visit type were key predictors, underscoring the need for targeted guidance. Findings are limited by self-reporting and single-center design but offer direction for integrating digital support into pediatric care.

Conclusion: One-third of caregivers utilized the internet for children's health information, with higher education and acute visit reasons as key determinants.

前言:研究印度东部三级儿科门诊(OPD)护理人员的互联网健康信息寻求行为及其决定因素。方法:横断面研究于2022年9月至12月在印度Deoghar的全印度医学科学研究所(AIIMS)儿科门诊部进行。采用面对面访谈的方式,编制了一份包含13个项目的有效问卷,以获取人口统计信息和互联网健康信息寻求行为。统计分析,包括多变量逻辑回归,确定了重要的决定因素。结果:门诊以急性病为主(39.3%),其次为慢性病监测(19.5%)和急性病随访(19.3%)。大约34.4%的护理人员在网上寻求健康信息。网络健康信息寻求行为与受教育程度和访问原因显著相关。受过高等中等教育或研究生学位的护理人员在网上寻求健康信息的可能性分别是前者的7.5倍和7.6倍。急性或急性随访患者的风险分别高出2.2倍和3.5倍。多变量模型解释了32.4%的变异性,预测准确率为74.1%。讨论:在线卫生信息搜索的普及率相对较低,突出了数字卫生素养方面的区域差距。教育水平和访问类型是关键的预测因素,强调需要有针对性的指导。研究结果受到自我报告和单中心设计的限制,但为将数字支持整合到儿科护理中提供了方向。结论:三分之一的护理人员利用互联网获取儿童健康信息,其中高等教育和急症访问原因是主要决定因素。
{"title":"Exploring Internet Health Information Seeking Behavior of Caregivers in a Tertiary Pediatric Outpatient Setting in Eastern India.","authors":"Manoj Kumar, Swati Swati, Rajan Kumar, Bijit Biswas","doi":"10.2174/0115733963380997250823060812","DOIUrl":"https://doi.org/10.2174/0115733963380997250823060812","url":null,"abstract":"<p><strong>Introduction: </strong>To study internet health information-seeking behavior and its determinants among caregivers in a tertiary Pediatric Outpatient Department (OPD) in Eastern India.</p><p><strong>Methods: </strong>A cross-sectional study was conducted between September and December 2022 at the Pediatric Outpatient Department of the All India Institute of Medical Sciences (AIIMS), Deoghar, India. A 13-item validated questionnaire was administered through face-to-face interviews, capturing demographic information and internet health information-seeking behavior. Statistical analyses, including multivariable logistic regression, identified significant determinants.</p><p><strong>Results: </strong>Outpatient visits were primarily for acute diseases (39.3%), followed by chronic disease monitoring (19.5%) and acute follow-ups (19.3%). Approximately 34.4% of caregivers sought health information online. Internet health information-seeking behavior was significantly associated with higher educational attainment and visit reasons. Caregivers with higher secondary education or graduate degrees were 7.5 and 7.6 times more likely, respectively, to seek health information online. Those attending for acute or acute follow-up visits had 2.2- and 3.5-times higher odds, respectively. The multivariable model explained 32.4% variability and had a predictive accuracy of 74.1%.</p><p><strong>Discussion: </strong>The relatively low prevalence of online health information-seeking highlights regional gaps in digital health literacy. Education level and visit type were key predictors, underscoring the need for targeted guidance. Findings are limited by self-reporting and single-center design but offer direction for integrating digital support into pediatric care.</p><p><strong>Conclusion: </strong>One-third of caregivers utilized the internet for children's health information, with higher education and acute visit reasons as key determinants.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144999969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigating High-risk Neonatal Intensive Care Unit (NICU) Care: Insights from the Newborn Behavioral Observation (NBO). 高危新生儿重症监护病房(NICU)护理:来自新生儿行为观察(NBO)的见解。
IF 1.6 Q3 PEDIATRICS Pub Date : 2025-08-27 DOI: 10.2174/0115733963376442250821002230
Maria Maddalena Brambilla, Chiara Petrolini, Virginia Beretta, Elena Scarpa, Sabrina Moretti, Paola Palanza, Serafina Perrone

The birth of a baby is a significant milestone for both parents, marking a major life transition into parenthood. In high-risk situations, such as preterm delivery, this event disrupts functional adaptation and greatly impacts parents' ability to recognize and effectively respond to their newborn's physiological and developmental needs. Positive interactions and sensitive responses to an infant's needs enable parents to foster development, supporting regulatory processes and establishing healthy social interaction patterns. The Newborn Behavioral Observation (NBO) Early Intervention is a prevention-focused follow-up program initiated shortly after birth during a developmental window when the infant's brain is highly receptive to environmental influences, maximizing its impact on infant development. Recent applications of the NBO intervention in at-risk contexts have shown promising effects on both infant development and the parent-infant relationship. This educational mini-review aims to summarize the main findings and future prospects of using the NBO to support the transition to parenthood from birth through the first months of life, particularly in high-risk environments such as intensive care units.

孩子的出生对父母双方来说都是一个重要的里程碑,标志着人生向为人父母的重大转变。在高危情况下,如早产,这一事件破坏了功能适应,极大地影响了父母识别和有效应对新生儿生理和发育需求的能力。积极的互动和对婴儿需求的敏感反应使父母能够促进发展,支持调节过程并建立健康的社会互动模式。新生儿行为观察(NBO)早期干预是一项以预防为重点的随访计划,在婴儿出生后不久,在婴儿大脑高度接受环境影响的发育窗口期,最大限度地发挥其对婴儿发育的影响。最近在风险环境中应用的NBO干预对婴儿发育和亲子关系都显示出有希望的效果。这篇教育性的小型综述旨在总结使用NBO来支持从出生到生命最初几个月向父母过渡的主要发现和未来前景,特别是在高危环境中,如重症监护病房。
{"title":"Navigating High-risk Neonatal Intensive Care Unit (NICU) Care: Insights from the Newborn Behavioral Observation (NBO).","authors":"Maria Maddalena Brambilla, Chiara Petrolini, Virginia Beretta, Elena Scarpa, Sabrina Moretti, Paola Palanza, Serafina Perrone","doi":"10.2174/0115733963376442250821002230","DOIUrl":"https://doi.org/10.2174/0115733963376442250821002230","url":null,"abstract":"<p><p>The birth of a baby is a significant milestone for both parents, marking a major life transition into parenthood. In high-risk situations, such as preterm delivery, this event disrupts functional adaptation and greatly impacts parents' ability to recognize and effectively respond to their newborn's physiological and developmental needs. Positive interactions and sensitive responses to an infant's needs enable parents to foster development, supporting regulatory processes and establishing healthy social interaction patterns. The Newborn Behavioral Observation (NBO) Early Intervention is a prevention-focused follow-up program initiated shortly after birth during a developmental window when the infant's brain is highly receptive to environmental influences, maximizing its impact on infant development. Recent applications of the NBO intervention in at-risk contexts have shown promising effects on both infant development and the parent-infant relationship. This educational mini-review aims to summarize the main findings and future prospects of using the NBO to support the transition to parenthood from birth through the first months of life, particularly in high-risk environments such as intensive care units.</p>","PeriodicalId":11175,"journal":{"name":"Current Pediatric Reviews","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144999925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Pediatric Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1